CSB 2.008 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.008 Note
CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s.
161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
CSB 2.008 Note
(hm) Drotebanol;
CSB 2.008 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.008 Note
CSB 2.06 Addition of pentazocine to schedule III. Subsection
(4m) of s.
161.18, Stats., schedule III is hereby created to read as follows:
CSB 2.008 Note
(4m) Pentazocine.
CSB 2.008 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.008 Note
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection
(3) (intro.) of s.
161.14, Stats., schedule I is amended to read:
CSB 2.008 Note
(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.008 Note
(2) Paragraph (em) of sub. (3), s.
161.16, Stats., schedule II, is hereby created to read:
CSB 2.008 Note
(em) Etorphine hydrochloride;
CSB 2.008 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.008 Note
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s.
161.16, Stats., schedule II is hereby created to read:
CSB 2.008 Note
(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.008 Note
(2) Paragraph
(n) of sub.
(2) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(n) Mebutamate
CSB 2.008 Note
(3) Paragraph
(b) of sub.
(2m) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(b) Pemoline:
CSB 2.008 History
History:
Cr.
Register, February, 1976, No. 242, eff. 3-1-76.
CSB 2.008 Note
CSB 2.09 Additions to schedules IV and I. (1)
Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s.
161.20, Stats., schedule IV are hereby created to read:
CSB 2.008 Note
(cm) Chlordiazepoxide
CSB 2.008 Note
(cn) Clonazepam
CSB 2.008 Note
(cp) Chlorazepate
CSB 2.008 Note
(cr) Diazepam
CSB 2.008 Note
(em) Flurazepam
CSB 2.008 Note
(hm) Oxazepam
CSB 2.008 Note
(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.008 Note
(u) Thiophene analog of phencyclidine
CSB 2.008 Note
(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s.
161.14, Stats., schedule I are hereby created to read:
CSB 2.008 Note
(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
CSB 2.008 Note
(a) Mecloqualone
CSB 2.008 Note
(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.008 Note
(hg) Difenoxin
CSB 2.008 Note
(5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s.
161.14, Stats., schedule I are hereby created to read:
CSB 2.008 Note
(v) 2,5-dimethoxyamphetamine
CSB 2.008 Note
(w) 4-bromo-2,5-dimethoxyamphetamine
CSB 2.008 Note
(x) 4-methoxyamphetamine
CSB 2.008 History
History:
Cr.
Register, April, 1976, No. 244, eff. 5-1-76.
CSB 2.008 Note
CSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.008 Note
(wn) Propiram
CSB 2.008 History
History:
Cr.
Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.008 Note
CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.008 Note
(b) Fenfluramine
CSB 2.008 Note
Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.008 Note
(a) Diethylpropion
CSB 2.008 Note
Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.008 Note
(c) Pemoline
CSB 2.008 NoteParagraph (d) of sub. (2m), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(d) Phentermine
CSB 2.008 History
History:
Cr.
Register, August, 1976, No. 248, eff. 9-1-76.
CSB 2.008 Note
CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
CSB 2.008 Note
(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
CSB 2.008 History
History:
Cr.
Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.008 Note
CSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(km) Prazepam
CSB 2.008 History
History:
Cr.
Register, November, 1977, No. 263, eff. 12-1-77.
CSB 2.008 Note
CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s.
161.14, Stats., is created to read:
CSB 2.008 Note
(mn) Parahexyl
CSB 2.008 Note
(2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
CSB 2.008 Note
(3) Paragraph (nm) of sub. (2), s.
161.20, Stats., is created to read:
CSB 2.008 Note
(nm) Triazolam
CSB 2.008 History
History:
Cr.
Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.008 Note
CSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.
CSB 2.008 Note
(2) Section
161.16 (3) (y), Stats., is created to read:
CSB 2.008 Note
(y) Sufentanil
CSB 2.008 History
History:
Cr.
Register, October, 1984, No. 346, eff. 11-1-84.
CSB 2.008 Note
CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s.
161.14 (5), Stats., is adopted to read:
CSB 2.008 Note
(b) Methaqualone
CSB 2.008 Note
(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.
CSB 2.008 Note
(4) Subsection
(10) (a) of s.
161.16, Stats., is created to read:
CSB 2.008 Note
(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
CSB 2.008 History
History:
Cr.
Register, August, 1986, No. 368, eff. 9-1-86;
CR 03-056: r. (1)
Register January 2004 No. 577, eff. 2-1-04.
CSB 2.008 Note
CSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(am) 3, 4-methylenedioxymethamphetamine, commonly known as“MDMA";
CSB 2.008 History
History:
Cr.
Register, September, 1987, No. 381, eff. 10-1-87.
CSB 2.008 Note
CSB 2.19 Additions, deletions and transfers to statutory schedules. (1) Paragraph (b) of s.
161.20 (4), Stats., is created to read:
CSB 2.008 Note
(b) Not more than 25 milligrams per dosage unit of pentazocine with one or more active, non-narcotic ingredients in recognized therapeutic amounts.
CSB 2.008 Note
(2) Paragraph (b) of s. 161.18 (4), Stats., is repealed.
CSB 2.008 Note
(3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
CSB 2.008 Note
(mg) Prazepam;
CSB 2.008 Note
(4) Paragraph (hg) of s.
161.20 (2), Stats., is created to read:
CSB 2.008 Note
(hg) Midazolam;
